Zentalis Pharmaceuticals, Inc.
Institutional Ownership & Holdings Analysis
About
zentalis-pharmaceuticals is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Matrix Capital Management Company, LP(2025-03-31) | $22.2M |
2 | EVENTIDE ASSET MANAGEMENT, LLC(2024-12-31) | $13.6M |
3 | BlackRock, Inc.(2025-03-31) | $6.7M |
4 | VANGUARD GROUP INC(2025-03-31) | $5.2M |
5 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $4.9M |
6 | ACADIAN ASSET MANAGEMENT LLC(2025-03-31) | $4.2M |
7 | MPM BioImpact LLC(2024-12-31) | $3.4M |
8 | Decheng Capital LLC(2025-03-31) | $3.2M |
9 | Integral Health Asset Management, LLC(2024-12-31) | $3.2M |
10 | Opaleye Management Inc.(2025-03-31) | $3.2M |
11 | Almitas Capital LLC(2025-03-31) | $2.7M |
12 | TANG CAPITAL MANAGEMENT LLC(2025-03-31) | $2.4M |
13 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $2.2M |
14 | STATE STREET CORP(2025-03-31) | $2.1M |
15 | PRIMECAP MANAGEMENT CO/CA/(2025-03-31) | $2.0M |
16 | Nuveen Asset Management, LLC(2024-12-31) | $1.9M |
17 | BANK OF AMERICA CORP /DE/(2025-03-31) | $1.8M |
18 | D. E. Shaw & Co., Inc.(2025-03-31) | $1.8M |
19 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD(2025-03-31) | $1.5M |
20 | PFIZER INC(2025-03-31) | $1.5M |
As of 2025-03-31
Value:$22.2M
As of 2024-12-31
Value:$13.6M
As of 2025-03-31
Value:$6.7M
As of 2025-03-31
Value:$5.2M
As of 2025-03-31
Value:$4.9M
As of 2025-03-31
Value:$4.2M
As of 2024-12-31
Value:$3.4M
As of 2025-03-31
Value:$3.2M
As of 2024-12-31
Value:$3.2M
As of 2025-03-31
Value:$3.2M
As of 2025-03-31
Value:$2.7M
As of 2025-03-31
Value:$2.4M
As of 2025-03-31
Value:$2.2M
As of 2025-03-31
Value:$2.1M
As of 2025-03-31
Value:$2.0M
As of 2024-12-31
Value:$1.9M
As of 2025-03-31
Value:$1.8M
As of 2025-03-31
Value:$1.8M
As of 2025-03-31
Value:$1.5M
#20PFIZER INC
As of 2025-03-31
Value:$1.5M
Total Institutional Holders:159
Top 10 Holders Own:58.9%